Research and Markets: New Report Examines the Competing in the U.S. Contract Research Market
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/b92f8c/competing_in_the_u) has announced the addition of Frost & Sullivan's new report "Competing in the U.S. Contract Research Market" to their offering. This study encompasses vital feedback provided by outsourcing decision makers within pharmaceutical and biotechnology companies allowing contract research organizations (CROs) to gain insight into current and future outsourcing patterns and trends. Through the analysis provided, CROs will better be able to understand motives and perceived benefits of outsourcing, criteria for CRO selection and current and future technology requirements. Additionally, competitive factors across CROs are analyzed with a special focus on the nation's leading CROs. An analysis of clinical trial trends and patterns across regions will allow CROs to understand where future growth opportunities may lie. CROs will be able to use this valuable data to better understand how decisions are made by their pharmaceutical and biotechnology customers, thereby allowing them to further penetrate this dynamic and lucrative market. There is some indication of a trend towards significant reductions in CRO budgets in the next 12 to 24 months for the majority of institutions surveyed. The source of this reduction appears to be an overall expectation of decline in outsourcing costs, most likely due to intensifying competition, rather from a decline in the rate of outsourcing itself. This implies that CROs need to have a firmer grasp of what the market really wants, and how they evaluate CROs, to stay competitive in a scenario of tightening CRO budgets. Oncology and Cardiovascular research will continue to be areas with higher levels of outsourcing, with some slight increase expected for Oncology research. A slight increase is also expected in the area of Metabolic Diseases. There are also indications of a possible slight decrease in the percentage of clinical development outsourced in the area of Allergy / Respiratory Diseases. Other potential trends and shifts across various areas of research and the various phases are evaluated in the study. The market can be segmented into 3 types of clients, based on their research priorities and criteria for selecting CROs. The Full Service user is the largest segment (47 percent), though relatively more selective in both its scope and intensity of outsourcing, it has more sophisticated requirements, and seeks technology services and data scalability. Heavy users (13 percent) have the highest intensity of outsourcing and pursue a broad spectrum of research areas. Price and Productivity Users (40 percent) consider price and the speed of project turnaround as important. The study discusses each of these segments' motives, priority areas and phases, and criteria for CRO selection. This implies that CROs should know how to emphasize key capabilities that match each particular segment's key criteria and research agenda to optimize its marketing and sales effectiveness. There is some indication of a possible slight shift in clinical trial activities from North America to other regions. North America share of clinical trials is expected to decrease from 61 percent to 53 percent in the next 3-5 years. The regions that will benefit from this shift are discussed in the study. Key Topics Covered: 1. Competing in the U.S. Contract Research Market 1.1 Executive Summary 1.2 Objectives and Methodology 1.3 Outsourcing Patterns and Trends 1.4 Motives and Perceived Benefits of Outsourcing 1.5 CRO Utilization, Satisfaction, and Preferences 1.6 Market Segments and Criteria for CRO Selection 1.7 CRO Performance Metrics 1.8 CROs Associated with Attributes 1.9 An Evaluation of 11 Large CROs 1.10 Patterns and Trends of Clinical Trials Across Regions 1.11 Other Technology Requirements: Current and Future 1.12 Purchase Behavior and Trends For more information visit http://www.researchandmarkets.com/research/b92f8c/competing_in_the_u Research and Markets Laura Wood Senior Manager press@researchandmarkets.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009
© Thomson Reuters 2009 All rights reserved



